Evidence map›Paper›PMID 25261112›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2014

Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases.

Irfan A Qureshi, Mark F Mehler

Abstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Epigenetics and Neurological Disorders in ART.International journal of molecular sciences · 2019
    Review
  6. Article
  7. Review
  8. Epigenetic mechanisms underlying nervous system diseases.Handbook of clinical neurology · 2018
    Review
  9. Review
  10. Neurogenetic disease: genes, mechanisms, and future promise.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2014
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Irfan A QureshiRoslyn and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA, irfan@jhu.edu.
Mark F Mehler

Funding

Support for MRRC - Biometry CoreP30HD001799 · NICHD · YESHIVA UNIVERSITY · PI FABER, DONALD S · 1985 to 2005
$6.5M
Translational Neuroimaging CoreP30HD071593 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WALKLEY, STEVEN UPSHAW · 2011 to 2015
$5.6M
Mechanisms Regulating Astroglial Lineage DevelopmentR01MH066290 · NIMH · YESHIVA UNIVERSITY · PI MEHLER, MARK F · 2002 to 2006
$1.8M
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?R01NS071571 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MEHLER, MARK F · 2010 to 2013
$1.3M
NICHD NIH HHS HD071593NICHD NIH HHS P30 HD001799NICHD NIH HHS P30 HD071593NIMH NIH HHS MH66290NIMH NIH HHS R01 MH066290NINDS NIH HHS NS071571NINDS NIH HHS R01 NS071571
6 · The paper itself

Abstract

There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology-which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states-and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.

Indexed as

Epigenesis, GeneticEpigenomicsHumansNervous System Diseases

Identifiers

PMID25261112
PMCPMC4391378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.